Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.23 EUR | +0.04% | +1.39% | +97.76% |
Mar. 22 | MorphoSys Gets US Antitrust Approval for Proposed Acquisition by Novartis | MT |
Mar. 22 | Novartis' EUR2.7 Billion Purchase of MorphoSys Secures US Antitrust Clearance | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+97.76% | 2.73B | |
+9.31% | 45.97B | |
+52.78% | 43.93B | |
+8.11% | 42.34B | |
-8.78% | 28.27B | |
+17.88% | 27.18B | |
-20.91% | 19.44B | |
+14.45% | 13.83B | |
+32.12% | 12.4B | |
+9.88% | 11.45B |
- Stock
- Equities
- Stock MorphoSys AG - Xetra
- News MorphoSys AG
- JPMorgan Downgrades MorphoSys to Underweight From Neutral, Price Target is $2.9